Press "Enter" to skip to content

New patent expiration for Rhodes Pharms drug DILAUDID

2
Copyright © DrugPatentWatch. Originally published at New patent expiration for Rhodes Pharms drug DILAUDID

Annual Drug Patent Expirations for DILAUDID
Annual Drug Patent Expirations for DILAUDID

Dilaudid is a drug marketed by Fresenius Kabi Usa and Rhodes Pharms and is included in three NDAs. It is available from three suppliers. There are three patents protecting this drug and four Paragraph IV challenges.

DILAUDID drug price trends.

Drug patent litigation for DILAUDID.

This drug has thirty-five patent family members in fifteen countries.

The generic ingredient in DILAUDID is hydromorphone hydrochloride. Three suppliers are listed for this compound. Additional details are available on the hydromorphone hydrochloride profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent expiration for Rhodes Pharms drug DILAUDID
Get the DrugPatentWatch Daily Briefing

✓ Patent Expirations and Generic Entry

✓ Insightful Articles & Case Studies

✓ Patent Litigation & Challenges

✓ 505(b)(2) & Biosimilars

✓ Industry Trends

DrugPatentWatch - Make Better Decisions